文献速递青光眼

青光眼初治后抑郁症状的纵向趋势与预测因素:CIGTS研究

Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS).
PubMed 文献 · Am J Ophthalmol · 2018-09-21

基于CIGTS试验607例新诊断开角型青光眼患者随访数据,基线平均CES-D评分为2.4,12.5%存在轻度或更重抑郁症状;治疗1年后各项抑郁指标明显下降,但基线视功能相关生活质量较差者抑郁风险更高。建议眼科医生主动询问抑郁症状并适时转诊。

要点

  • 新诊断青光眼患者基线12.5%存在轻度或更重抑郁症状。
  • 治疗1年后抑郁指标明显下降,此后仅轻度下降。
  • 基线VRQOL较差、女性、年轻、低教育水平预测抑郁。

核心结论

  • 青光眼治疗启动后第一年内抑郁症状明显下降,但视功能相关生活质量受损者抑郁症状仍较高。

研究设计与样本

  • CIGTS临床试验随访数据的队列研究,1993年10月至1997年4月在美国14个中心纳入607例新诊断开角型青光眼患者,随机接受药物或手术治疗,每6个月随访至2004年。

主要发现

  • 基线平均CES-D评分为2.4(SD=3.8),12.5%报告轻度或更重抑郁症状,55.3%报告至少1种抑郁症状。
  • 治疗1年时CES-D评分降至1.5,轻度或更重抑郁比例为6.7%,至少1种抑郁症状比例为38.4%,此后仅轻度下降。
  • 基线预测轻度或更重抑郁的因素包括视功能相关生活质量较差(OR=2.41)、女性(OR=1.42)、年轻(每年轻10岁OR=1.24)、低于高中教育(OR=2.93)。

临床怎么用

  • 眼科医生应主动询问青光眼患者抑郁症状,适当给予 reassurance 并在必要时转诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To characterize longitudinal trends and factors predictive of depressive symptoms following glaucoma diagnosis in Collaborative Initial Glaucoma Treatment Study (CIGTS) participants. DESIGN: Cohort study using follow-up data from a clinical trial. METHODS: A total of 607 participants with newly diagnosed open-angle glaucoma were enrolled at 14 clinical centers in the United States from October 1993 through April 1997, randomized to treatment with medication or surgery, and followed every 6 months through 2004. The 8-item Center for Epidemiologic Studies Depression Scale (CES-D) was administered at baseline and follow-up visits. Three outcome measures were investigated: overall CES-D depression score, presence of mild or worse depression (CES-D score ≥ 7), and number of depressive symptoms endorsed. RESULTS: The average baseline CES-D score was 2.4 (SD = 3.8), 12.5% of subjects reported symptoms associated with mild or worse depression, and 55.3% reported at least 1 depressive symptom. By 1 year posttreatment, depression measures decreased (1.5, 6.7%, and 38.4%, respectively), with modest decreases thereafter. Baseline factors predictive of mild or worse depression included worse vision-related quality of life (VRQOL) (odds ratio [OR] = 2.41), female sex (OR = 1.42), younger age (OR per 10 years younger = 1.24), and less than high school education (OR = 2.93); other outcomes showed similar results. CONCLUSIONS: Depressive symptoms decreased considerably during the first year after treatment initiation, but were elevated in those with impaired VRQOL. Given the potential of depression to reduce treatment adherence and thus increase the risk of glaucoma progression, eye care providers should ask patients about depressive symptoms, provide reassurance when appropriate, and make referrals as necessary.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Musch DC, Niziol LM, Janz NK, et al. Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol. 2018. PMID: 30248311. doi:10.1016/j.ajo.2018.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。